Health

DENVER (AP) — The owner of a Catholic clinic challenging Colorado's new ban on unproven treatments to reverse medication abortions testified Monday that a state pledge not to enforce the ban for now wasn't enough to protect her staff and patients.

JEFFERSON CITY, Mo. (AP) — The Missouri ACLU on Monday sued to block new state restrictions on both adults and children seeking gender-affirming health care, which are set to kick in Thursday.

MADISON, Wis. (AP) — Republican U.S. Sen. Ron Johnson on Monday renewed his call for a statewide vote in Wisconsin on abortion rights, saying he thought most voters would support a ban after 12 weeks of pregnancy.

IQALUIT, Nunavut — The City of Iqaluit says its water treatment plant is to return to service Tuesday morning, more than a year after it was shut down due to contamination.

No one has been fined in Ontario so far under a new law that can require patients to pay a daily $400 penalty if they refuse to move from a hospital to a long-term care home not of their choosing, the province and its hospitals say.

At age 93, struggling with the effects of a stroke, heart failure and recurrent cancer, Teri Sheridan was ready to end her life using New Jersey's law that allows medically assisted suicide -- but she was bedbound, too sick to travel. So last Nov.

EAGLE RIVER, Alaska (AP) — Thousands of Alaskans who depend on government assistance have waited months for food stamp benefits, exacerbating a long-standing hunger crisis worsened by the pandemic, inflation and the remnants of a typhoon that wiped o

SALT LAKE CITY (AP) — As a third grader in Utah, mandolin-playing math whiz Elle Palmer said aloud what she had only before sensed, telling a friend she planned to transfer schools the following year and hoped her new classmates would see her as a gi

WASHINGTON (AP) — Nothing will change for now. That's what the Supreme Court said Friday evening about access to a widely used abortion pill.

Health Canada has approved a new antibody drug to help protect babies from serious illness caused by respiratory syncytial virus, or RSV. Nirsevimab, also known by its brand name Beyfortus, was authorized on April 19.